Iaso Therapeutics to Showcase Novel mQβ Vaccine Platform at 2026 World Vaccine Congress
PR Newswire —
EAST LANSING, Mich., Feb. 18, 2026 /PRNewswire/ -- Iaso Therapeutics, Inc., a biotechnology company redefining infectious disease prevention with its novel synthetic vaccine platform, today announced that it will present at the 2026 World Vaccine Congress in Washington, D.C., on Tuesday,...